Can we optimize the CEA as a response marker in rectal cancer?
CONCLUSIONS: lower pre-treatment CEA/ExT values seem to be associated with tumor downstaging, and this parameter may be promising as a predictor of a more favorable response in patients with rectal ADC undergoing treatment with N-CRT.
PMID: 33228364 [PubMed - as supplied by publisher]
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Tags: Rev Esp Enferm Dig Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Study